ArticleOncotarget2018

Rhodocetin-αβ selectively breaks the endothelial barrier of the tumor vasculature in HT1080 fibrosarcoma and A431 epidermoid carcinoma tumor models.

Stephan Niland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.